[When the blood cells suffer after a TAVR]

Jeremy Boyer; Thomas Cuisset; Pierre Deharo

doi:10.1016/j.ancard.2024.101793

[When the blood cells suffer after a TAVR]

Ann Cardiol Angeiol (Paris). 2024 Sep;73(4):101793. doi: 10.1016/j.ancard.2024.101793. Epub 2024 Aug 6.

[Article in French]

Authors

Jeremy Boyer¹, Thomas Cuisset², Pierre Deharo³

Affiliations

¹ Département de Cardiologie, CHU Timone, Marseille, France.
² Département de Cardiologie, CHU Timone, Marseille, France; Aix Marseille Univ, Inserm, Inra, C2VN, Marseille, France.
³ Département de Cardiologie, CHU Timone, Marseille, France; Aix Marseille Univ, Inserm, Inra, C2VN, Marseille, France. Electronic address: pierre.deharo@ap-hm.fr.

PMID: 39111135
DOI: 10.1016/j.ancard.2024.101793

Abstract

We present here a case of documented paraprosthetic valvular leak following TAVI treated medically initially. This led to a poorly tolerated hemolytic anemia. We were able to correct this paraprosthetic valvular leak by a postdilation of the TAVI valve with a good result and uncomplicated follow-up.

Keywords: Anemia; Anémie; Fuite paraprothétique; Paravalvular leak; TAVI.

Publication types

Case Reports
English Abstract

MeSH terms

Aged
Aged, 80 and over
Anemia, Hemolytic* / etiology
Aortic Valve Stenosis* / surgery
Female
Heart Valve Prosthesis / adverse effects
Humans
Male
Postoperative Complications / etiology
Prosthesis Failure
Transcatheter Aortic Valve Replacement* / adverse effects